Medical Scientific and Advisory Board
Stephan Moll, MD, University of North Carolina, Chapel Hill, NC; Chair of Medical and Scientific and Advisory Board
Dr.
Stephan Moll received his medical school training in Freiburg , Germany , and
London , England . He trained 5 years in Medicine and Hematology-Oncology at
Duke University in Durham , NC , and 1 year in Clinical Coagulation at the
University of North Carolina in Chapel Hill (UNC). He has been on faculty
at UNC in the Department of Medicine, Division of Hematology-Oncology since 1999
and heads the UNC Thrombophilia Program.
Dr. Moll is a clinician, clinical researcher, and clinical educator. Most of his time is spent seeing patients with clotting disorders, conducting clinical research relating to thrombosis and thrombophilia, and educating health care providers, patients and public in various ways on thrombosis and thrombophilia. Dr. Moll has 4 children. He likes hiking, bicycling and traveling.
Jack Ansell, MD, Boston University, Boston, MA
Jack E. Ansell, MD, is Professor of Medicine at Boston University School of Medicine. He serves as Vice Chairman for Clinical Affairs in the Department of Medicine at Boston University Medical Center and as Medical Director for the Boston University Medical Group.
After receiving his medical degree from the University of Virginia School of Medicine in Charlottesville, Virginia, Dr. Ansell completed an internship and residency at Tufts New England Medical Center in Boston, Massachusetts. Dr. Ansell then completed a fellowship in hematology at Boston University and in hematology/hemostasis at Boston’s Veterans Administration Hospital.
Dr. Ansell’s main areas of interest and research include hemostasis and thrombosis, with a special emphasis on thrombotic disorders and antithrombotic therapy. He has had a continued interest and involvement in the application of new modes of delivering and monitoring anticoagulants, particularly in the management of oral anticoagulant therapy.
Dr. Ansell has approximately 170 publications in notable journals such as Annals of Internal Medicine, The New England Journal of Medicine, and The Journal of the American Medical Association. His publishing activity includes reviews, editorials, textbooks, videos, abstracts, and letters. He serves as an associate editor for the Journal of Thrombosis and Thrombolysis and as an editorial consultant for such journals as The New England Journal of Medicine, Blood, Thrombosis and Haemostasis, and Circulation.
Dr. Ansell is the founder and Chair of the Anticoagulation Forum, a network of anticoagulation clinics throughout North America, and is a member of a number of professional organizations including the American College of Physicians (Fellow), the American Society of Hematology, the International Society of Thrombosis and Hemostasis and its Scientific Subcommittee on Haemostasis Testing, the American Heart Association (Fellow), and the American Medical Association. Dr. Ansell also serves as Chair of the Committee on Managing Oral Anticoagulation for the American College of Chest Physicians Consensus Conference on Antithrombotic Therapy
Kenneth A. Bauer, MD, Harvard Medical School, Boston, MA
Dr
Bauer is Professor of Medicine at Harvard Medical School in Boston ,
Massachusetts . His hospital positions include Chief, Hematology Section, VA
Boston Healthcare System, and Director, Thrombosis Clinical Research, Beth
Israel Deaconess Medical Center . Dr Bauer received his medical degree from
Stanford University School of Medicine in Stanford , California . He completed
his residency in medicine at the University of Chicago Hospitals and Clinics in
Illinois.
Edward Libby, MD; University of New Mexico, Albequerque, NM
Dr.
Libby received and completed his Internal Medicine residency and Hematology
fellowship at the University of New Mexico Health Sciences Center in
Albuquerque, New Mexico. He has been interested in the care of patients with
thrombotic diseases since 1996 when he assumed the directorship of the UNM
Anticoagulation Clinic.
Kenneth Mann, PhD, University of Vermont, Burlington, VT
Dr. Mann received his Ph.D. in Biochemistry (C.S. Vestling) at the University of
Iowa. After additional post- doctoral training in physical biochemistry at Duke
University (C. Tanford), he moved to the University of Minnesota as an Assistant
Professor. His interest in applying Physical Biochemistry techniques to
elucidating the varied physical and functional interactions of proteins in the
blood coagulation process was encouraged by a joint appointment at the Mayo
Clinic (Mayo Medical School), where he achieved the rank of Professor of
Biochemistry and Medicine and became Vice Chair of the Department of Medicine.
He came to the University of Vermont in 1984 as Professor and Chair of
Biochemistry, and he relinquished the Chair in 2005. Dr. Mann has received many
National and international awards, including the E. Donnall Thomas Award (ASH),
the Sherry Award (AHA) and the Wood Medal (ISTH).
Elizabeth Varga, MS, CGC; Columbus Children's Research Institute, Columbus, OH
Liz
learned she had factor V Leiden in 2000 after she was tested due to a family
history of the disorder. Liz is a certified genetic counselor and has 5 years of
experience in educating patients, families, health care providers and the public
about inherited disorders and disease prevention, specifically as related to
thrombophilia. As the Chairperson of the NATT Education Committee, she helps
develop and maintain the organization’s website, produces and edits numerous
patient education materials and presentations, and organizes and implements
information seminars for health care providers and the public. She also serves
as a liaison to the Centers for Disease Control and Prevention to foster
collaboration among public and private groups involved with preventing or
reducing the complications of clotting disorders. Ms. Varga’s commitment to NATT
is based on her desire to see improvements in health care education related to
thrombosis and thrombophilia. Liz currently works as a genetic counselor and
research coordinator at Children’s Research Institute in Columbus, OH.eavarga@hotmail.com
Andra James, MD, MPH; Duke University, Durham, NC
Dr. Andra H. James is a maternal-fetal medicine specialist and an Assistant
Professor in the Department of Obstetrics and Gynecology at the Duke University
Medical Center. She a Co-Director of Duke’s Comprehensive Hemostasis and
Thrombosis Center and founder of the Women’s Hemostasis and Thrombosis Clinic
there. Her practice, research and publications pertain to reproductive issues
among women with bleeding and clotting disorders.
Bruce Evatt, MD, formerly Center for Disease Control, Atlanta, GA
John Heit, MD, Mayo Clinic; Rochester, MN
Full Clinical and Research Profile can be found at:
http://mayoresearch.mayo.edu/mayo/research/staff/heit_ja.cfm
Marilyn Manco-Johnson, MD; University of Colorado, Denver, CO
Jeffrey Weitz, MD, Hamilton Regional Cancer Centre, Hamilton, Ontario
Profile available at: http://www.fhs.mcmaster.ca/biochem/dir/fac/weitz.htm